SCHEMBL11262539

SCHEMBL11262539

O=[N+]([O-])[CH]c1ccccc1[N+](=O)[O-]

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.55
▸ CA12 O43570 1/20 0.51
▸ SOS1 Q07889 1/20 0.51
▸ XDH P47989 2/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50
▸ MAOB P27338 1/20 0.50
▸ ERN1 O75460 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ MEN1 O00255 6/20 0.47
▸ KMT2A Q03164 6/20 0.47
▸ TDP1 Q9NUW8 1/20 0.46
▸ NPC1 O15118 4/20 0.46
▸ RAB9A P51151 4/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ NFKB1 P19838 1/20 0.46
▸ NFKB2 Q00653 1/20 0.46
▸ RELA Q04206 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ GAA P10253 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14935499 0.82 MAPT (0.69) MAPTCA12SOS1NPSR1MAOB
SCHEMBL11049170 0.82 MAPT (0.69) MAPTCA12SOS1NPSR1MAOB
SCHEMBL9978289 0.82 MAPT (0.69) MAPTCA12SOS1NPSR1MAOB
SCHEMBL114440 0.82 MAPT (0.58) MAPTCA12SOS1XDHNPSR1
SCHEMBL11296000 0.80 MAPT (0.67) MAPTCA12SOS1NPSR1MAOB
2-Nitrobenzaldehyde SCHEMBL5654 0.80 ERN1 (0.66) MAPTCA12SOS1XDHNPSR1
2-Nitrobenzaldehyde SCHEMBL29672618 0.80 ERN1 (0.66) MAPTCA12SOS1XDHNPSR1
SCHEMBL11299049 0.80 MAPT (0.67) MAPTCA12SOS1NPSR1MAOB
SCHEMBL4361353 0.79 MAPT (0.61) MAPTSOS1MAOBMEN1KMT2A
SCHEMBL4307048 0.79 MAPT (0.61) MAPTSOS1MAOBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10894803-B2 Multi-functionalized polysaccharide compounds and use thereof for targeting the cation-independent mannose 6-phosphate receptor NANOMEDSYN (FR) 2021-01-19 — — US disclosed
US-20180265534-A1 MULTI-FUNCTIONALIZED POLYSACCHARIDE COMPOUNDS AND USE THEREOF FOR TARGETING THE CATION-INDEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2018-09-20 — — US disclosed
US-4341706-A Process for the preparation of carbapenem antibiotics MERCK & CO., INC. (US) 1982-07-27 — — US disclosed
US-4262009-A AMINO ACID DERIVATIVE ANTIBIOTICS MERCK & CO., INC. (US) 1981-04-14 — — US disclosed
US-4262011-A AMINO ACID DERIVATIVE ANTIBIOTICS MERCK & CO., INC. (US) 1981-04-14 — — US disclosed
US-4208422-A ANTIBIOTICS, BACTERICIDES MERCK & CO., INC. (US) 1980-06-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180265534-A1 MULTI-FUNCTIONALIZED POLYSACCHARIDE COMPOUNDS AND USE THEREOF FOR TARGETING THE CATION-INDEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR M6PR, IGF2R, MPI MAPT 3933/4885CA12 196/4885SOS1 4433/4885
US-10894803-B2 Multi-functionalized polysaccharide compounds and use thereof for targeting the cation-independent mannose 6-phosphate receptor M6PR, IGF2R, MPI MAPT 3885/4885CA12 229/4885SOS1 4388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback